Jiang Su Yida Chemical Co.,Ltd (SHE:300721)
China · Delayed Price · Currency is CNY 20.60
+0.60 (3.00%)
May 6, 2026, 3:05 PM CST
SHE:300721 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Operating Revenue | 1,811 | 1,596 | 1,734 | 1,744 | 1,492 | 1,442 |
Other Revenue | - | - | 33.63 | 69.79 | 62.74 | 8.24 |
| 1,811 | 1,596 | 1,768 | 1,814 | 1,554 | 1,450 | |
Revenue Growth (YoY) | 6.62% | -9.74% | -2.55% | 16.72% | 7.16% | 44.44% |
Cost of Revenue | 1,758 | 1,595 | 1,580 | 1,614 | 1,268 | 1,152 |
Gross Profit | 52.96 | 1.24 | 188.12 | 200.34 | 286.39 | 298.25 |
Selling, General & Admin | 86.72 | 87.17 | 124.38 | 197.43 | 90.71 | 78.72 |
Research & Development | 15.21 | 16.56 | 21.82 | 25.04 | 24.5 | 24.93 |
Other Operating Expenses | 6.59 | 4.72 | 2.9 | 2.79 | 11.22 | 9.72 |
Operating Expenses | 108.52 | 108.46 | 148.7 | 227.54 | 125.9 | 114.6 |
Operating Income | -55.56 | -107.21 | 39.42 | -27.2 | 160.5 | 183.65 |
Interest Expense | - | - | -45.43 | -48.21 | -36.65 | -25.67 |
Interest & Investment Income | - | - | 1.1 | 2.46 | 2.52 | 1.35 |
Currency Exchange Gain (Loss) | - | - | 0.81 | 0.64 | -0.42 | -0.14 |
Other Non Operating Income (Expenses) | -46.93 | -47.46 | -0.32 | -0.27 | -0.24 | -0.2 |
EBT Excluding Unusual Items | -102.48 | -154.68 | -4.42 | -72.58 | 125.7 | 159 |
Gain (Loss) on Sale of Assets | 0.01 | 0.04 | -0.12 | 0.01 | -0.13 | -0.07 |
Asset Writedown | 0.9 | -7.7 | -0.22 | -1.98 | -2.44 | - |
Legal Settlements | - | - | -2 | - | - | - |
Other Unusual Items | - | - | 0.39 | 1.61 | -2.15 | 1.45 |
Pretax Income | -101.58 | -162.35 | -6.37 | -72.94 | 120.98 | 160.37 |
Income Tax Expense | -13.64 | -29.21 | -3.73 | -20.27 | 17.46 | 29.37 |
Earnings From Continuing Operations | -87.93 | -133.14 | -2.65 | -52.66 | 103.52 | 131 |
Minority Interest in Earnings | 19.09 | 23.78 | 12.18 | 17.37 | 6.06 | 0.84 |
Net Income | -68.85 | -109.36 | 9.53 | -35.29 | 109.58 | 131.84 |
Net Income to Common | -68.85 | -109.36 | 9.53 | -35.29 | 109.58 | 131.84 |
Net Income Growth | - | - | - | - | -16.88% | - |
Shares Outstanding (Basic) | 165 | 165 | 165 | 145 | 162 | 161 |
Shares Outstanding (Diluted) | 165 | 165 | 165 | 145 | 165 | 162 |
Shares Change (YoY) | -0.28% | -0.05% | 13.94% | -12.02% | 1.51% | 9.81% |
EPS (Basic) | -0.42 | -0.66 | 0.06 | -0.24 | 0.68 | 0.82 |
EPS (Diluted) | -0.42 | -0.66 | 0.06 | -0.24 | 0.67 | 0.81 |
EPS Growth | - | - | - | - | -18.12% | - |
Free Cash Flow | 106.06 | -12.86 | 142.6 | -125.13 | -83.19 | -20.04 |
Free Cash Flow Per Share | 0.64 | -0.08 | 0.86 | -0.86 | -0.51 | -0.12 |
Dividend Per Share | - | - | 0.030 | 0.100 | 0.079 | 0.053 |
Dividend Growth | - | - | -70.00% | 26.74% | 50.00% | - |
Gross Margin | 2.92% | 0.08% | 10.64% | 11.04% | 18.43% | 20.56% |
Operating Margin | -3.07% | -6.72% | 2.23% | -1.50% | 10.33% | 12.66% |
Profit Margin | -3.80% | -6.85% | 0.54% | -1.94% | 7.05% | 9.09% |
Free Cash Flow Margin | 5.85% | -0.81% | 8.07% | -6.90% | -5.35% | -1.38% |
EBITDA | 127.1 | 61.21 | 150.92 | 124.85 | 227.27 | 237.81 |
EBITDA Margin | 7.02% | 3.84% | 8.54% | 6.88% | 14.62% | 16.40% |
D&A For EBITDA | 182.65 | 168.42 | 111.5 | 152.05 | 66.78 | 54.16 |
EBIT | -55.56 | -107.21 | 39.42 | -27.2 | 160.5 | 183.65 |
EBIT Margin | -3.07% | -6.72% | 2.23% | -1.50% | 10.33% | 12.66% |
Effective Tax Rate | - | - | - | - | 14.43% | 18.31% |
Revenue as Reported | - | - | 1,768 | 1,814 | 1,554 | 1,450 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.